ReviewNanoscale research letters2020
Enzyme-Free Glucose Biosensors Based on MoS
Review in Nanoscale research letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- A D-Shaped Polymer Optical Fiber Surface Plasmon Resonance Biosensor for Breast Cancer Detection Applications.Biosensors · 2023Article
- Copper nanoparticles/polyaniline/molybdenum disulfide composite as a nonenzymatic electrochemical glucose sensor.Heliyon · 2023Article
- Alzheimer's Disease Biomarker Detection Using Field Effect Transistor-Based Biosensor.Biosensors · 2023Review
- Multifunctional Biosensing Platform Based on Nickel-Modified Laser-Induced Graphene.Bioengineering (Basel, Switzerland) · 2023Article
- Recent Developments and Future Perspective on Electrochemical Glucose Sensors Based on 2D Materials.Biosensors · 2022Review
- Glycated Hemoglobin and Methods for Its Point of Care Testing.Biosensors · 2021Article
- Mo-Based Layered Nanostructures for the Electrochemical Sensing of Biomolecules.Sensors (Basel, Switzerland) · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-performance glucose biosensors are highly desired for healthcare. To meet these demands, glucose biosensors, particularly enzyme-free glucose biosensors, have received much attention. Two-dimensional materials, e.g., graphene, with high surface area, excellent electrical properties, and good biocompatibility, have been the main focus of biosensor research in the last decade. This review presents the recent progress made in enzyme-free glucose biosensors based on MoS
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.